We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Preliminary Phase II Results Of Abiraterone Acetate In Patients With Castration-resistant Metastatic Prostate Cancer
Clinical Trials / Drug Trials UroToday.com - Dr. Danila, spoke about abiraterone acetate (AA), an oral and irreversible inhibitor of CYP17 that decreases testosterone and DHT levels to undetectable. The study presented sought to determine the proportion of patients achieving a PSA decline of >50% and to assess toxicity. It was a multicenter trial using AA 1000mg orally daily and prednisone 5mg daily. Successful AA activity was defined as a PSA decline >50% in >30% of patients.
